These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4199834)

  • 21. Treatment of aged psychotic patients with hydergine.
    Freeman H; Murray P
    Gerontol Clin (Basel); 1966; 8(5):279-84. PubMed ID: 4960136
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of an ergot preparation (hydergine) in the convalescent phase of stroke.
    Bochner F; Eadie MJ; Tyrer JH
    J Am Geriatr Soc; 1973 Jan; 21(1):10-7. PubMed ID: 4630036
    [No Abstract]   [Full Text] [Related]  

  • 24. An ergot preparation (Hydergine) for relief of symptoms of cerebrovascular insufficiency.
    Banen DM
    J Am Geriatr Soc; 1972 Jan; 20(1):22-4. PubMed ID: 4628906
    [No Abstract]   [Full Text] [Related]  

  • 25. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ergot alkaloid preparation (Hydergine) in the treatment of presenile brain atrophy (Alzheimer's disease): case report.
    Burian E
    J Am Geriatr Soc; 1974 Mar; 22(3):126-8. PubMed ID: 4204771
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 28. [Geriatric pharmacotherapy of the neurasthenic syndrome (an experimental psychological and clinical long term study)].
    Schnell R; Oswald WD
    Arztl Forsch; 1967 Dec; 21(12):464-70. PubMed ID: 4970409
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of treatment on symptomatology and correlated electroencephalographic (EEG) changes in the aged.
    Arrigo A; Braun P; Kauchtschischwili GM; Moglia A; Tartara A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):417-26. PubMed ID: 4198303
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of circulatory venous diseases: double-blind study with Sandovene].
    Lambelet F
    Schweiz Rundsch Med Prax; 1973 Jul; 62(29):925-9. PubMed ID: 4198273
    [No Abstract]   [Full Text] [Related]  

  • 31. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 32. [Analysis of the effect of Hydergin in long-term trial. An interdisciplinary study].
    Herzfeld U; Christian W; Oswald WD; Ronge J; Wittgen M
    Med Klin; 1972 Sep; 67(35):1118-25. PubMed ID: 4627270
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of cerebral insufficiency].
    Grill P; Broicher H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic results of H.M. 51 Sandoz (Visergil) in gerontopsychiatry].
    Besada Varela L
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(1):211-21. PubMed ID: 4198282
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mental effects of Wallerox therapy in the aged].
    Thomae H
    Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216
    [No Abstract]   [Full Text] [Related]  

  • 36. Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine).
    Rosen HJ
    J Am Geriatr Soc; 1975 Apr; 23(4):169-74. PubMed ID: 803997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 38. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 39. [Action of hydergine on cerebrovascular insufficiencies in hypertensive patients].
    Pacheco e Silva A
    Hospital (Rio J); 1970 Jul; 78(1):49-53. PubMed ID: 4991828
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the use of vitamin E nicotinate in cerebral diseases caused by debilitation].
    Poggi E; Sforzini D; Tosarelli L
    Sist Nerv; 1971; 23(7):126-32. PubMed ID: 5005842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.